More on PHAT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+60.0% Growth)
- Ratings (8.6 Score)
- FDA

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Phathom Pharmaceuticals Inc. (NQ:PHAT)
Delayed: 8.37 --0 (-0%)
Prev. Close $8.37  
Open$8.37 
52 Wk High$ 
52 Wk Low$ 
Day High$8.37 
Day Low$8.37 
P/E N/A  
EPS$ 
Volume1,203 

Friends, Peers and Foes (?): 2RH, CPIX RDHL (more...)

Sep 9, 2026 06:11 AM Leerink Starts Phathom Pharmaceuticals (PHAT) at Market Perform
Sep 1, 2026 08:01 AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 17, 2026 04:53 AM Phathom Pharmaceuticals (PHAT) PT Lowered to $14 at Barclays
Jul 31, 2026 06:47 AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
Jul 30, 2026 01:03 PM Phathom Pharmaceuticals (PHAT) PT Lowered to $22 at Guggenheim
Jul 30, 2026 07:36 AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q2 EPS by 19c
Jul 30, 2026 07:06 AM Form 10-Q Phathom Pharmaceuticals, For: Jun 30
Jul 30, 2026 07:05 AM Form 8-K Phathom Pharmaceuticals, For: Jul 30
Jul 30, 2026 06:59 AM Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 29, 2026 03:21 PM Form SCHEDULE 13G Phathom Pharmaceuticals, Filed by: BlackRock, Inc.
View All Articles

Entities mentioned with PHAT

View All Entities